Guardant Health Stock Price on April 12, 2024
| GH Stock | USD 30.44 0.93 2.96% |
Below is the normalized historical share price chart for Guardant Health extending back to October 04, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Guardant Health stands at 30.44, as last reported on the 28th of December, with the highest price reaching 31.38 and the lowest price hitting 30.14 during the day.
If you're considering investing in Guardant Stock, it is important to understand the factors that can impact its price. Guardant Health appears to be very steady, given 3 months investment horizon. Guardant Health holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14% return per unit of standard deviation over the last 3 months. By evaluating Guardant Health's technical indicators, you can evaluate if the expected return of 0.52% is justified by implied risk. Please utilize Guardant Health's market risk adjusted performance of (58.53), and Risk Adjusted Performance of 0.1248 to validate if our risk estimates are consistent with your expectations.
Guardant Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of October 2018 | 200 Day MA 26.0159 | 50 Day MA 29.445 | Beta 1.106 |
Guardant |
Sharpe Ratio = 0.1382
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.74 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.52 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Guardant Health is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Guardant Health by adding it to a well-diversified portfolio.
Price Book 55.6696 | Enterprise Value Ebitda (5.40) | Price Sales 5.433 | Shares Float 111.3 M | Wall Street Target Price 43.2 |
Related Headline
Myriad Genetics Headline on 12th of April 2024
Disposition of 1076 shares by Mark Verratti of Myriad Geneti... by Mark Verratti
Filed transaction by Myriad Genetics Officer: Chief Commercial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Guardant Health Valuation on April 12, 2024
It is possible to determine the worth of Guardant Health on a given historical date. On April 12, 2024 Guardant was worth 18.42 at the beginning of the trading date compared to the closed value of 18.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Guardant Health stock. Still, in general, we apply an absolute valuation method to find Guardant Health's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Guardant Health where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Guardant Health's related companies.
| Open | High | Low | Close | Volume | |
| 19.35 | 19.41 | 18.32 | 18.68 | 1,113,315 | |
04/12/2024 | 18.42 | 18.58 | 17.96 | 18.26 | 1,308,053 |
| 18.34 | 18.45 | 16.94 | 17.06 | 2,701,134 |
| Backtest Guardant Health | | | Guardant Health History | | | Guardant Health Valuation | Previous | Next |
Guardant Health Trading Date Momentum on April 12, 2024
| On April 15 2024 Guardant Health was traded for 17.06 at the closing time. The highest price during the trading period was 18.45 and the lowest recorded bid was listed for 16.94 . The volume for the day was 2.7 M. This history from April 15, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 6.57% . The overall trading delta to the current price is 8.11% . |
Guardant Health Fundamentals Correlations and Trends
By evaluating Guardant Health's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Guardant Health's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Guardant financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Guardant Health Stock history
Guardant Health investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Guardant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Guardant Health will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Guardant Health stock prices may prove useful in developing a viable investing in Guardant Health
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1373 people.
Guardant Health Quarterly Net Working Capital |
|
Guardant Health Stock Technical Analysis
Guardant Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Guardant Health Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Guardant Health cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Guardant Health December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Guardant Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Guardant Health shares will generate the highest return on investment. By undertsting and applying Guardant Health stock market strength indicators, traders can identify Guardant Health entry and exit signals to maximize returns
Guardant Health Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Guardant Health's price direction in advance. Along with the technical and fundamental analysis of Guardant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Guardant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1248 | |||
| Jensen Alpha | 0.5271 | |||
| Total Risk Alpha | 0.4251 | |||
| Sortino Ratio | 0.1775 | |||
| Treynor Ratio | (58.54) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |